|
THE SIMPLE FACTSTM...Trasylol, also known as aprotinin, has been in use worldwide since the 1990s to reduce bleeding related to heart bypass surgery (CABG).
Based on the latest data, it appears that over four and a half million people had been given the drug, and over a million were in the United States. Trasylol is made by Bayer AG.
Some of the patients who were given the drug Trasylol have suffered chronic renal failure (requiring long term kidney dialysis), died after surgery, died of kidney failure, died of heart failure, died of heart attacks and died of strokes.
TRASYLOL: When is it used?
Trasylol is used during open heart surgery, heart bypass, heart valve replacement and other cardiac surgery to control bleeding.
TRASYLOL: What do leading medical journals say?
A major study recently published in the New England Journal of Medicine found that Trasylol significantly raised the risk of death compared to competing products and that patients given Trasylol had a more than 50 percent higher death rate than patients who were given alternative, cheaper blood clotting drugs.
For more information on Trasylol, click here.
Quite frankly, THE SIMPLE FACTSTM about the Bayer AG drug Trasylol® used during heart surgery and the possible injuries - renal failure, kidney damage, kidney failure, long term dialysis, heart damage, heart failure, heart attack, stroke and possibly death - that may be caused by the use of Trasylol during open heart surgery (CABG) are unacceptable.
We are investigating claims of renal failure, kidney damage, kidney failure, long term dialysis, heart damage, heart failure, heart attack, stroke and death in connection with possible side effects and problems from the use of the drug Trasylol following open heart surgery (CABG).
In addition, an MDL has been setup in the Southern District of Florida for Trasylol litigation (IN RE: Trasylol Products Liability Litigation No. 1928).
We are here to help you protect your legal rights and the legal rights of your loved ones.
|
